Rexel Pharma (India) Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2000.
2000 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Rexel Pharma (India) Private Limited

Rexel Pharma (India) Private Limited, a struck off private limited company, was established on 24 October 2000 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230MH2000PTC129343. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Manoj Kumar Jain (Director Appointed In Casual Vacancy), Gautam Gajra (Director). Past directors included Rajkumar Jain. Its latest AGM occurred on 30 September 2009, with the balance sheet filed on 31 March 2009. It is based at Elve Chambers Green Street Fort, Mumbai, Maharashtra, 400023.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2000PTC129343

  • Registration Number

    129343

  • Incorporation Date

    24 October 2000

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 25 Year, 7 Months
  • Last Filing with ROC 31 Mar 2009
Company report

Rexel Pharma (India) Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Rexel Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rexel Pharma (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Manoj Kumar Jain Director Appointed In Casual Vacancy 31 Mar 2008 Current
Gautam Gajra Director 24 Oct 2000 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rexel Pharma (India).

Enhance accessibility to Rexel Pharma (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Rexel Pharma (India) revenue growth over time
Rexel Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rexel Pharma (India)?

Unlock access to Rexel Pharma (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rexel Pharma (India)?

Unlock and access historical data on people associated with Rexel Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rexel Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexel Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rexel Pharma (India)
Recent Activity within the Organization
  • Annual General Meeting

    The activity Rexel Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2009 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Rexel Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2009 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Manoj Kumar Jain was appointed as a Director appointed in casual vacancy was appointed as a Director appointed in casual vacancy on 31 Mar 2008 & has been associated with this company since 18 years 2 months . was completed.

  • Director Appointment

    Progress on Gautam Gajra was appointed as a Director was appointed as a Director on 24 Oct 2000 & has been associated with this company since 25 years 7 months . was documented.

  • Company Incorporation

    Progress on Rexel Pharma (India) Private Limited was registered on 24 Oct 2000 with Roc Mumbai & aged 25 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rexel Pharma (India) Private Limited?

The CIN of Rexel Pharma (India) Private Limited is U24230MH2000PTC129343.

Where is Rexel Pharma (India) Private Limited headquartered?

Rexel Pharma (India) Private Limited is headquartered at Elve Chambers Green Street Fort, Mumbai, Maharashtra, 400023.

When was Rexel Pharma (India) Private Limited incorporated?

Rexel Pharma (India) Private Limited was incorporated on 24 October 2000.

Who are the current directors of Rexel Pharma (India) Private Limited?

The current directors of Rexel Pharma (India) Private Limited are

What is the primary industry of Rexel Pharma (India) Private Limited?

The primary industry of Rexel Pharma (India) Private Limited is Chemicals.

Is Rexel Pharma (India) Private Limited a listed company?

Rexel Pharma (India) Private Limited is unlisted.

What is the capital structure of Rexel Pharma (India) Private Limited?

The authorized capital of Rexel Pharma (India) Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available